HRT explained clearly: benefits, risks and your options
Hormone replacement therapy can be one option for managing some menopause symptoms. The right choice depends on symptoms, health history, preferences and individual clinical advice.
Written by[Health Writer]·Medically reviewed by[Qualified Clinician]·Last reviewed: September 2026·Reviewed against current clinical guidance
ONE TREATMENT, MANY FORMS
Patch
Gel
Tablet
Spray & local forms
Different hormones, doses, combinations and delivery methods may be used.
THE SHORT ANSWER
HRT replaces hormones such as estrogen — and sometimes progesterone — that decline during the menopause transition. It may help symptoms such as hot flashes and night sweats, but benefits and risks vary between individuals.
HRT is not one single treatment. Different hormones, doses, delivery methods and combinations may be used.
This guide is educational and does not determine whether HRT is appropriate for you.
What is hormone replacement therapy?
During the menopause transition, levels of estrogen — and other hormones — change and eventually decline. For some women these changes cause few problems; for others they bring symptoms that affect sleep, comfort and daily life.
Hormone replacement therapy provides hormones to reduce some of these symptoms. What it involves depends entirely on the individual situation.
Menopause transitionChanging hormone levelsPossible symptomsHormone therapy may be discussed
Estrogen
The core hormone in most HRT. Declining estrogen is linked with many common menopause symptoms, and replacing it is the main way HRT works.
Progesterone
Usually added when a woman has a uterus, to protect the womb lining while taking estrogen.
Testosterone — in selected situations
Considered only in specific circumstances with specialist input. It is not a routine part of HRT. More below ↓
Which symptoms may HRT be used for?
HRT is most commonly discussed for vasomotor symptoms — hot flashes and night sweats — and for genitourinary symptoms. Its role in other symptoms depends on context.
Hot flashes
EVIDENCE SUMMARY: [Editable]
The most established use of systemic HRT.
Night sweats
EVIDENCE SUMMARY: [Editable]
Closely related to hot flashes as vasomotor symptoms.
Sleep disruption from vasomotor symptoms
CONTEXT-DEPENDENT
Sleep may improve when night sweats are treated.
Vaginal & urinary symptoms
EVIDENCE SUMMARY: [Editable]
Often addressed with local vaginal estrogen. See below ↓
Other menopause-related symptoms
DEPENDS ON CONTEXT
Mood, joint and other symptoms are discussed case by case — evidence and suitability vary. Evidence labels on this page are placeholders pending the editorial team’s rating methodology.
“HRT” covers several combinations of hormones and several ways of taking them. This matrix is a flexible summary — availability of specific combinations is confirmed during medical review.
TYPE
PATCH
GEL
SPRAY
TABLET
VAGINAL
Estrogen only
●
●
●
●
—
Combined estrogen + progesterone
●
[TBC]
[TBC]
●
—
Local vaginal estrogen
—
—
—
—
●
Other specialist approaches
Discussed individually with specialist input
● commonly available form · [TBC] confirmed during medical review · This component holds medically reviewed information; it is not a complete clinical matrix.
The appropriate type can depend on factors including:
Whether the person has a uterusSymptom patternPersonal health historyPreferencesRoute of administrationClinician advice
Benefits depend on the symptoms being treated, the type of HRT and the individual. Careful wording matters: HRT may help — it does not deliver every benefit to every user.
Relief of hot flashes — systemic HRT can reduce frequency and severity for many users.
Reduction in night sweats — and, for some, the sleep disruption they cause.
Improved quality of life for some users — when troublesome symptoms respond to treatment.
Support for bone health — in appropriate circumstances, estrogen can help protect bone density.
Improvement in certain vaginal or urinary symptoms — depending on treatment type, particularly local estrogen.
WHAT THE EVIDENCE SAYS
Current guidance: [Placeholder — summary of current clinical guidance on HRT benefits, added at medical review.]
Important limitations: [Placeholder — populations studied, duration of evidence, individual variation.]
What about risks?
HRT risks vary depending on factors such as age, health history, hormone type, route, duration and individual circumstances. Risk is not identical for every type of HRT.
Blood clots
Clot risk considerations can differ by route of administration and individual history. This is a key topic for clinical discussion.
Breast cancer considerations
Associations vary by HRT type, duration and individual factors. This deserves careful, personalized discussion rather than a single headline figure.
Stroke considerations
Age, route and cardiovascular history are among the factors clinicians weigh.
Endometrial protection
Estrogen without adequate progesterone can affect the uterine lining — the reason combined HRT exists for women with a uterus.
Other side effects
Breast tenderness, bleeding changes, bloating and other effects can occur, particularly in early months. See “after starting HRT” below ↓
Discuss personal risk with a qualified healthcare professional.
PUTTING RISK IN CONTEXT
Absolute risk matters more than scary headlines
Relative risk and absolute risk can tell very different stories. A “50% increase” of a very small number is still a small number — which is why we show risk per number of people, with sources.
Testosterone may be discussed in selected situations — most commonly for low sexual desire that persists despite conventional HRT. It is not a universal menopause treatment, is not intended for general symptoms like hot flashes, and typically involves specialist or experienced clinical guidance.
There is no single fixed duration. How long HRT is used depends on symptoms, benefits experienced, risks, age, preferences and regular clinical review.
1
Start with a plan
2
Regular review
3
Continue · adjust · reconsider
Duration is revisited at each review — no mandatory stopping point at a specific age is implied by guidance-led care.
Safety depends on individual factors — age, health history, HRT type and route. For many symptomatic women, guidance supports HRT as a reasonable option; for others, more caution applies.
For most women over 45, diagnosis and treatment discussions are usually based on symptoms rather than routine hormone blood tests. Testing may have a role in specific situations.
